The effects of Choto-san on the mRNA expression of Alzheimer's disease related factors in the permanent ischemic rat brain

Biological and Pharmaceutical Bulletin

Volumn 28, Issue 4, 2005, Pages 744-746

  Hayashi, Hisae ^a   Tohda, Michihisa ^a   Watanabe, Hiroshi ^a   Murakami, Yukihisa ^a   Matsumoto, Kinzo ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Alzheimer's disease; Choto san; mRNA expression; Neprilysin

Indexed keywords

AMYLOID PRECURSOR PROTEIN; BUNGAROTOXIN RECEPTOR; CHOTO SAN; CHRYSANTHEMUM MORIFOLIUM EXTRACT; CHYRSANTHEMUM INDICUM EXTRACT; CITRUS UNSHIU EXTRACT; GAMMA SECRETASE; GINGER EXTRACT; GINSENG EXTRACT; GLYCYRRHIZA EXTRACT; GYPSUM FIBROSUM EXTRACT; INSULINASE; KAMPO; MEMBRANE METALLOENDOPEPTIDASE; MESSENGER RNA; NICOTINIC RECEPTOR; OPHIOPOGON JAPONICUS EXTRACT; PINELLIA TERNATA EXTRACT; PLANT EXTRACT; PORIA COCOS EXTRACT; SAPOSHNIKOVA DIVARICATA EXTRACT; UNCARIA RHYNCHOPHYLLA EXTRACT; UNCARIA SINENSIS EXTRACT; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; CAROTID ARTERY; CAROTID ARTERY OBSTRUCTION; CONTROLLED STUDY; DRUG EFFECT; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; TREATMENT OUTCOME;

ALZHEIMER DISEASE; ANIMALS; BRAIN; BRAIN ISCHEMIA; DRUGS, CHINESE HERBAL; GENE EXPRESSION; GENE EXPRESSION PROFILING; MALE; MEDICINE, KAMPO; RATS; RATS, WISTAR; RNA, MESSENGER;

EID: 21144453720     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.28.744     Document Type: Article

References (17)

1. Ni J. W., Ohta H., Matsumoto K., Watanabe H., Brain Res., 653, 231-236 (1994).
2. Ni J. W., Matsumoto K., Li H. B., Murakami Y., Watanabe H., Brain Res., 673, 290-296 (1995).
3. Englund E., Brun A., Histopathology, 16, 433-439 (1990).
4. del Ser T., Bermejo F., Portera A., Arredondo J. M., Bouras C., Constantinidis J., J. Neurol. Sci., 96, 1-17 (1990).
5. Tohda M., Suwanakitch P., Jeenapongsa R., Hayashi H., Watanabe H., Biol. Pharm. Bull., 27, 2021-2023 (2004).
6. Watanabe H., Zhao Q., Matsumoto K., Tohda M., Murakami Y., Zhang S. H., Kang T. H., Mahakunakorn P., Maruyama Y., Sakakibara I., Aimi N., Takayama H., Pharmacol. Biochem. Behav., 75, 635-643 (2003).
7. Chomczynski P., Sacchi N., Anal. Biochem., 162, 156-159 (1987).
8. Zhang S., Murakami Y., Tohda M., Matsumoto K., Sakakibara I., Takayama H., Aimi N., Watanabe H., J. Trad. Med., 19, 28-36 (2001) [in Japanese].
9. Qi Z., Watanabe H., Murakami Y., Tohda M., Matsumoto K., J. Trad. Med., 19, 153-157 (2002). [in Japanese].
10. Jeenapongsa R., Tohda M., Watanabe H., J. Trad. Med., 20, 165-167 (2003).
11. Saito T., Takaki Y., Iwata N., Trojanowski J., Saido T. C., Sci. Aging Knowledge Environ., 2003, PE1 (2003).
12. Tohgi H., Abe T., Yamazaki K., Murata T., Isobe C., Ishizaki E., J. Neural Transm., 105, 1283-1291 (1998).
13. Tohda M., Matsumoto K., Hayashi H., Murakami Y., Watanabe H., J. Trad. Med., 21, 182-186 (2004).
14. Leissring M. A., Lu A., Condron M. M., Teplow D. B., Stein R. L., Farris W., Selkoe D. J., J. Biol. Chem., 278, 37314-37320 (2003).
15. Edland S. D., J. Mol. Neurosci., 23, 213-217 (2004).
16. Kang T. H., Matsumoto K., Tohda M., Murakami Y., Takayama H., Kitajima M., Aimi N., Watanabe H., Eur. J. Pharmacol., 444, 39-45 (2002).
17. Kang T. H., Murakami Y., Matsumoto K., Takayama H., Kitajima M., Aimi N., Watanabe H., Eur. J. Pharmacol., 455, 27-34 (2002).